STOCK TITAN

[Form 4] Arteris, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Arteris (NASDAQ:AIP) filed a Form 4 showing that VP & CFO Nicholas B. Hawkins sold a total of 11,276 common shares on 25-26 Jun 2025 under a pre-arranged Rule 10b5-1 plan.

  • Sales volume: 5,638 shares at $9.50 and 5,638 at $9.75, raising roughly $108k.
  • Ownership impact: holdings fell from 161,937 to 150,661 shares, a 7% reduction.
  • Plan history: the 10b5-1 plan was adopted 20 May 2024; no derivative transactions were reported.

The transaction is modest in dollar terms but material in percentage for a C-suite executive, potentially influencing short-term sentiment.

Arteris (NASDAQ:AIP) ha presentato un modulo Form 4 che mostra come il VP e CFO Nicholas B. Hawkins abbia venduto un totale di 11.276 azioni ordinarie il 25 e 26 giugno 2025, secondo un piano predefinito conforme alla regola 10b5-1.

  • Volume delle vendite: 5.638 azioni a 9,50$ e 5.638 azioni a 9,75$, per un ricavo di circa 108.000$.
  • Impatto sulla proprietà: le partecipazioni sono scese da 161.937 a 150.661 azioni, una riduzione del 7%.
  • Storia del piano: il piano 10b5-1 è stato adottato il 20 maggio 2024; non sono state segnalate transazioni derivanti.

La transazione è modesta in termini di valore monetario, ma significativa in percentuale per un dirigente di alto livello, potenzialmente influenzando il sentiment a breve termine.

Arteris (NASDAQ:AIP) presentó un Formulario 4 que muestra que el vicepresidente y CFO Nicholas B. Hawkins vendió un total de 11.276 acciones comunes los días 25 y 26 de junio de 2025 bajo un plan preestablecido conforme a la regla 10b5-1.

  • Volumen de ventas: 5.638 acciones a $9.50 y 5.638 a $9.75, recaudando aproximadamente $108,000.
  • Impacto en la propiedad: las participaciones disminuyeron de 161.937 a 150.661 acciones, una reducción del 7%.
  • Historial del plan: el plan 10b5-1 fue adoptado el 20 de mayo de 2024; no se reportaron transacciones de derivados.

La transacción es modesta en términos monetarios, pero significativa en porcentaje para un ejecutivo de alto nivel, lo que podría influir en el sentimiento a corto plazo.

Arteris (NASDAQ:AIP)는 부사장 겸 CFO인 Nicholas B. Hawkins가 2025년 6월 25일부터 26일까지 사전 설정된 Rule 10b5-1 계획에 따라 총 11,276주의 보통주를 매도했다는 내용을 담은 Form 4를 제출했습니다.

  • 매도량: 5,638주를 주당 $9.50에, 5,638주를 주당 $9.75에 매도하여 약 $108,000를 조달했습니다.
  • 소유 영향: 보유 주식은 161,937주에서 150,661주로 7% 감소했습니다.
  • 계획 내역: 10b5-1 계획은 2024년 5월 20일에 채택되었으며, 파생상품 거래는 보고되지 않았습니다.

이번 거래는 금액 면에서는 크지 않지만, 임원급 인사에게는 비율상 중요한 거래로 단기 투자 심리에 영향을 미칠 수 있습니다.

Arteris (NASDAQ:AIP) a déposé un formulaire 4 indiquant que le VP et CFO Nicholas B. Hawkins a vendu un total de 11 276 actions ordinaires les 25 et 26 juin 2025 dans le cadre d’un plan préalablement établi selon la règle 10b5-1.

  • Volume des ventes : 5 638 actions à 9,50 $ et 5 638 à 9,75 $, générant environ 108 000 $.
  • Impact sur la détention : le nombre d’actions détenues est passé de 161 937 à 150 661, soit une réduction de 7 %.
  • Historique du plan : le plan 10b5-1 a été adopté le 20 mai 2024 ; aucune transaction dérivée n’a été signalée.

La transaction est modeste en valeur monétaire mais significative en pourcentage pour un cadre dirigeant, ce qui pourrait influencer le sentiment à court terme.

Arteris (NASDAQ:AIP) reichte ein Formular 4 ein, das zeigt, dass VP und CFO Nicholas B. Hawkins am 25. und 26. Juni 2025 insgesamt 11.276 Stammaktien im Rahmen eines vorab vereinbarten Rule 10b5-1 Plans verkauft hat.

  • Verkaufsvolumen: 5.638 Aktien zu je 9,50 $ und 5.638 Aktien zu je 9,75 $, wodurch etwa 108.000 $ eingenommen wurden.
  • Auswirkung auf den Besitz: Die Beteiligungen sanken von 161.937 auf 150.661 Aktien, eine Reduktion um 7 %.
  • Planhistorie: Der 10b5-1 Plan wurde am 20. Mai 2024 eingeführt; keine Derivatgeschäfte wurden gemeldet.

Die Transaktion ist in Dollarwert bescheiden, aber prozentual für einen Führungskraft bedeutend und könnte kurzfristig die Stimmung beeinflussen.

Positive
  • None.
Negative
  • CFO insider sale: Nicholas B. Hawkins disposed of 11,276 shares (~7% of his holdings) for about $108k, which may weigh on investor sentiment despite 10b5-1 status.

Insights

TL;DR: CFO trims stake by 7%; small cash value yet negative optics.

The ~$108k disposal is insignificant to market cap but noteworthy because it removes 11,276 shares and comes just weeks before Q2 results. Although executed under a Rule 10b5-1 plan, investors often interpret any C-suite sale as a bearish signal. The CFO still retains 150,661 shares, so alignment remains, but further scheduled sales could snowball into sentiment pressure.

TL;DR: Pre-planned sale meets governance norms; limited strategic impact.

The trade follows the SEC's updated 10b5-1 cooling-off requirements, reducing information-asymmetry concerns. A 7% reduction keeps Hawkins’ residual stake above typical alignment thresholds, suggesting liquidity rather than outlook-driven motives. Without accompanying negative news, governance risk stays low, rendering the overall impact neutral.

Arteris (NASDAQ:AIP) ha presentato un modulo Form 4 che mostra come il VP e CFO Nicholas B. Hawkins abbia venduto un totale di 11.276 azioni ordinarie il 25 e 26 giugno 2025, secondo un piano predefinito conforme alla regola 10b5-1.

  • Volume delle vendite: 5.638 azioni a 9,50$ e 5.638 azioni a 9,75$, per un ricavo di circa 108.000$.
  • Impatto sulla proprietà: le partecipazioni sono scese da 161.937 a 150.661 azioni, una riduzione del 7%.
  • Storia del piano: il piano 10b5-1 è stato adottato il 20 maggio 2024; non sono state segnalate transazioni derivanti.

La transazione è modesta in termini di valore monetario, ma significativa in percentuale per un dirigente di alto livello, potenzialmente influenzando il sentiment a breve termine.

Arteris (NASDAQ:AIP) presentó un Formulario 4 que muestra que el vicepresidente y CFO Nicholas B. Hawkins vendió un total de 11.276 acciones comunes los días 25 y 26 de junio de 2025 bajo un plan preestablecido conforme a la regla 10b5-1.

  • Volumen de ventas: 5.638 acciones a $9.50 y 5.638 a $9.75, recaudando aproximadamente $108,000.
  • Impacto en la propiedad: las participaciones disminuyeron de 161.937 a 150.661 acciones, una reducción del 7%.
  • Historial del plan: el plan 10b5-1 fue adoptado el 20 de mayo de 2024; no se reportaron transacciones de derivados.

La transacción es modesta en términos monetarios, pero significativa en porcentaje para un ejecutivo de alto nivel, lo que podría influir en el sentimiento a corto plazo.

Arteris (NASDAQ:AIP)는 부사장 겸 CFO인 Nicholas B. Hawkins가 2025년 6월 25일부터 26일까지 사전 설정된 Rule 10b5-1 계획에 따라 총 11,276주의 보통주를 매도했다는 내용을 담은 Form 4를 제출했습니다.

  • 매도량: 5,638주를 주당 $9.50에, 5,638주를 주당 $9.75에 매도하여 약 $108,000를 조달했습니다.
  • 소유 영향: 보유 주식은 161,937주에서 150,661주로 7% 감소했습니다.
  • 계획 내역: 10b5-1 계획은 2024년 5월 20일에 채택되었으며, 파생상품 거래는 보고되지 않았습니다.

이번 거래는 금액 면에서는 크지 않지만, 임원급 인사에게는 비율상 중요한 거래로 단기 투자 심리에 영향을 미칠 수 있습니다.

Arteris (NASDAQ:AIP) a déposé un formulaire 4 indiquant que le VP et CFO Nicholas B. Hawkins a vendu un total de 11 276 actions ordinaires les 25 et 26 juin 2025 dans le cadre d’un plan préalablement établi selon la règle 10b5-1.

  • Volume des ventes : 5 638 actions à 9,50 $ et 5 638 à 9,75 $, générant environ 108 000 $.
  • Impact sur la détention : le nombre d’actions détenues est passé de 161 937 à 150 661, soit une réduction de 7 %.
  • Historique du plan : le plan 10b5-1 a été adopté le 20 mai 2024 ; aucune transaction dérivée n’a été signalée.

La transaction est modeste en valeur monétaire mais significative en pourcentage pour un cadre dirigeant, ce qui pourrait influencer le sentiment à court terme.

Arteris (NASDAQ:AIP) reichte ein Formular 4 ein, das zeigt, dass VP und CFO Nicholas B. Hawkins am 25. und 26. Juni 2025 insgesamt 11.276 Stammaktien im Rahmen eines vorab vereinbarten Rule 10b5-1 Plans verkauft hat.

  • Verkaufsvolumen: 5.638 Aktien zu je 9,50 $ und 5.638 Aktien zu je 9,75 $, wodurch etwa 108.000 $ eingenommen wurden.
  • Auswirkung auf den Besitz: Die Beteiligungen sanken von 161.937 auf 150.661 Aktien, eine Reduktion um 7 %.
  • Planhistorie: Der 10b5-1 Plan wurde am 20. Mai 2024 eingeführt; keine Derivatgeschäfte wurden gemeldet.

Die Transaktion ist in Dollarwert bescheiden, aber prozentual für einen Führungskraft bedeutend und könnte kurzfristig die Stimmung beeinflussen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hawkins Nicholas B.

(Last) (First) (Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300

(Street)
CAMPBELL CA 95008

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP and Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/25/2025 S(1) 5,638 D $9.5 156,299 D
Common Stock 06/26/2025 S(1) 5,638 D $9.75 150,661 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on May 20, 2024.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for Hawkins Nicholas B. 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did AIP's CFO sell on June 25-26 2025?

He sold 5,638 shares at $9.50 on June 25 and 5,638 at $9.75 on June 26, totaling 11,276 shares.

What percentage of his holdings did the sale represent?

The two transactions reduced his stake from 161,937 to 150,661 shares, a decline of roughly 7%.

Was the transaction executed under a Rule 10b5-1 trading plan?

Yes. The filing states the trades were made pursuant to a 10b5-1 plan adopted on May 20 2024.

How many shares does Nicholas B. Hawkins still own after the sale?

He beneficially owns 150,661 common shares following the reported transactions.

What was the total cash value of the shares sold?

Approximately $108,500 based on the disclosed sale prices of $9.50 and $9.75.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Latest News

AIP Latest SEC Filings

AIP Stock Data

364.79M
28.63M
33.09%
43.37%
0.82%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL